These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27033080)

  • 1. Methods for PTEN in Stem Cells and Cancer Stem Cells.
    Schubbert S; Jiao J; Ruscetti M; Nakashima J; Wu S; Lei H; Xu Q; Yi W; Zhu H; Wu H
    Methods Mol Biol; 2016; 1388():233-85. PubMed ID: 27033080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.
    Ciuffreda L; Falcone I; Incani UC; Del Curatolo A; Conciatori F; Matteoni S; Vari S; Vaccaro V; Cognetti F; Milella M
    Adv Biol Regul; 2014 Sep; 56():66-80. PubMed ID: 25088603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN, stem cells, and cancer stem cells.
    Hill R; Wu H
    J Biol Chem; 2009 May; 284(18):11755-9. PubMed ID: 19117948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN inhibits BMI1 function independently of its phosphatase activity.
    Fan C; He L; Kapoor A; Rybak AP; De Melo J; Cutz JC; Tang D
    Mol Cancer; 2009 Nov; 8():98. PubMed ID: 19903340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry.
    Groszer M; Erickson R; Scripture-Adams DD; Dougherty JD; Le Belle J; Zack JA; Geschwind DH; Liu X; Kornblum HI; Wu H
    Proc Natl Acad Sci U S A; 2006 Jan; 103(1):111-6. PubMed ID: 16373498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI(3)king apart PTEN's role in cancer.
    Zhang S; Yu D
    Clin Cancer Res; 2010 Sep; 16(17):4325-30. PubMed ID: 20622047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles.
    Stiles BL
    Int J Biochem Cell Biol; 2009 Apr; 41(4):757-61. PubMed ID: 18950730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN and leukemia stem cells.
    Fragoso R; Barata JT
    Adv Biol Regul; 2014 Sep; 56():22-9. PubMed ID: 24961634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade.
    Liu JL; Mao Z; LaFortune TA; Alonso MM; Gallick GE; Fueyo J; Yung WK
    Cancer Res; 2007 Nov; 67(22):11054-63. PubMed ID: 18006852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN in the haematopoietic system and its therapeutic indications.
    Cheung AM; Mak TW
    Trends Mol Med; 2006 Nov; 12(11):503-5. PubMed ID: 16996801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey.
    Knobbe CB; Lapin V; Suzuki A; Mak TW
    Oncogene; 2008 Sep; 27(41):5398-415. PubMed ID: 18794876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
    Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
    Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.
    Yilmaz OH; Valdez R; Theisen BK; Guo W; Ferguson DO; Wu H; Morrison SJ
    Nature; 2006 May; 441(7092):475-82. PubMed ID: 16598206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells.
    Ricci-Vitiani L; Mollinari C; di Martino S; Biffoni M; Pilozzi E; Pagliuca A; de Stefano MC; Circo R; Merlo D; De Maria R; Garaci E
    FASEB J; 2010 Nov; 24(11):4291-301. PubMed ID: 20566622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells.
    Shim JH; Kim YS; Bahk YY
    Proteomics; 2006 Jan; 6(1):81-93. PubMed ID: 16294307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN regulates phospholipase D and phospholipase C.
    Alvarez-Breckenridge CA; Waite KA; Eng C
    Hum Mol Genet; 2007 May; 16(10):1157-63. PubMed ID: 17405772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein-protein interaction-mediated inactivation of PTEN.
    De Melo J; He L; Tang D
    Curr Mol Med; 2014 Jan; 14(1):22-33. PubMed ID: 24236460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity.
    Meuillet EJ; Mahadevan D; Berggren M; Coon A; Powis G
    Arch Biochem Biophys; 2004 Sep; 429(2):123-33. PubMed ID: 15313215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.